Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Pre-Close Trading Statement

17 Apr 2024 07:00

RNS Number : 8541K
De La Rue PLC
17 April 2024
 

 

17 April 2024 

De La Rue plc

Pre-close trading update

De La Rue plc ("De La Rue", the "Group" or the "Company") today gives a trading update for the financial year ended 30 March 2024 ("FY24").

For FY24, the Group expects adjusted operating profit to be in line with guidance previously given, in the low £20m range. Net debt is expected to be around £90m, which is marginally better than previous guidance. In addition, the Authentication division is expected to report revenue in excess of £100m, as previously targeted.

The Group's results for the period ended 30 March 2024 will be announced on 18 June 2024.

As previously noted, the Board intends to provide an update by 31 May 2024 on progress in optimising the underlying intrinsic value of the business for the benefit of all stakeholders.

 

Enquiries

 

De La Rue plc

+44 (0)7990 337707

Clive Vacher

Chief Executive Officer

Dean Moore

Interim Chief Financial Officer

Louise Rich

Head of Investor Relations

Brunswick

+44 (0)207 404 5959

Stuart Donnelly

Ed Brown

 

About De La Rue

Established over 210 years ago, De La Rue is trusted by governments, central banks, and international brands, providing digital and physical solutions that protect their supply chains and cash cycles from counterfeiting and illicit trade.

With operations in five continents, customers in 140 countries and solutions that include advanced track and trace software, security document design, banknotes, brand protection labels, tax stamps, security features and passport bio-data pages, De La Rue brings unparalleled knowledge and expertise to its partnerships and projects.

Our core focus areas are:

- Authentication: leveraging advanced digital software solutions and security labels to protect revenues and reputations from the impacts of illicit trade, counterfeiting, and identity theft.

- Currency: designing and manufacturing highly secure banknotes and banknote components that are optimised for security, manufacturability, cash cycle efficacy and public engagement.

The security and trust derived from our solutions pave the way for robust economies and flourishing societies. This is underpinned by a significant Environmental, Social, and Governance commitment that is evidenced by accolades such as the ISO 14001 certification and a consistent ranking in the top tier of the Financial Times European Climate Leaders list.

De La Rue's shares are traded on the London Stock Exchange (LSE: DLAR). De La Rue plc's LEI code is 213800DH741LZWIJXP78. For further information please visit www.delarue.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTIFMATMTBBBJI
Date   Source Headline
9th Jul 20201:38 pmRNSHolding(s) in Company
8th Jul 20203:58 pmRNSDirector/PDMR Shareholding
6th Jul 20202:20 pmRNSResults of Capital Raising and General Meeting
3rd Jul 20202:31 pmRNSHolding(s) in Company
2nd Jul 20205:46 pmRNSHolding(s) in Company
1st Jul 202010:46 amRNSBlock listing Interim Review
23rd Jun 202011:48 amRNSHolding(s) in Company
17th Jun 20202:15 pmRNSPublication of Prospectus
17th Jun 20207:01 amRNSProposed Capital Raising
17th Jun 20207:00 amRNS2019/20 FULL YEAR RESULTS AND ANNUAL REPORT 2020
16th Jun 20207:00 amRNSSFO INVESTIGATION CLOSURE
1st Jun 20207:00 amRNSTRADING AND COVID-19 UPDATE
6th May 20207:00 amRNSFULL YEAR ANNOUNCEMENT DATE
27th Apr 20205:57 pmRNSDisclosure of Rights Attached to Equity Shares
1st Apr 202012:28 pmRNSTotal Voting Rights
31st Mar 20207:00 amRNSTrading Update
27th Mar 20209:31 amRNSHolding(s) in Company
24th Mar 202010:35 amRNSHolding(s) in Company
9th Mar 20205:28 pmRNSHolding(s) in Company
5th Mar 20205:44 pmRNSHolding(s) in Company
25th Feb 20205:48 pmRNSHolding(s) in Company
25th Feb 20207:00 amRNSTURNAROUND AND TRADING UPDATE
10th Feb 20202:00 pmRNSCHIEF FINANCIAL OFFICER APPOINTMENT
4th Feb 20206:05 pmRNSDirector Declaration
3rd Feb 20202:38 pmRNSTotal Voting Rights
29th Jan 20203:53 pmRNSHolding(s) in Company
24th Jan 202010:44 amRNSDirectorate Change
7th Jan 20205:13 pmRNSHolding(s) in Company
7th Jan 20205:09 pmRNSDirector/PDMR Shareholding
7th Jan 20205:05 pmRNSDirector/PDMR Shareholding
6th Jan 20204:58 pmRNSHolding(s) in Company
2nd Jan 202010:58 amRNSBlock listing Interim Review
2nd Jan 202010:52 amRNSTotal Voting Rights
19th Dec 20192:58 pmRNSDirector/PDMR Shareholding
16th Dec 201912:46 pmRNSDirector/PDMR Shareholding
4th Dec 20196:19 pmRNSDirector/PDMR Shareholding
3rd Dec 20193:36 pmRNSHolding(s) in Company
2nd Dec 201910:07 amRNSTotal Voting Rights
29th Nov 20192:09 pmRNSDirector/PDMR Shareholding
28th Nov 20194:20 pmRNSDirector/PDMR Shareholding
26th Nov 20196:44 pmRNSDirector/PDMR Shareholding
26th Nov 20197:00 amRNS2019/20 HALF YEAR RESULTS
21st Nov 20193:00 pmRNSAdditional Listing
13th Nov 20193:03 pmRNSHolding(s) in Company
8th Nov 20194:56 pmRNSHolding(s) in Company
31st Oct 20195:05 pmRNSTotal Voting Rights
30th Oct 20197:00 amRNSTrading Update
14th Oct 20193:59 pmRNSCompletion of Sale of ID Business
7th Oct 20195:53 pmRNSHolding(s) in Company
7th Oct 20194:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.